StockSelector.com
  Research, Select, & Monitor Friday, September 18, 2020 3:38:03 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Moderna, Inc.,$69.14$1.251.84%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Moderna, Inc., has an overall rank of 5547 out of 7548 stocks based on 10 positive rankings and 10 negative rankings.

Positive Rankings
Estimated Revenue Growth
Moderna, rank is 18
SSValue
The StockSelector Value for Moderna, is $998.56. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Moderna, is ranked 111.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Moderna, is ranked 137.
PEGValue
Moderna, has a PEG Value of $264.84. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 290.10% in the next year. Among companies with a PEG Value above the current stock price, Moderna, is ranked 301.
Beat Whisper
According to EarningsWhispers.com, Moderna, beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Target Prices
The average analysts' target price is $86.33 for Moderna, using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Moderna, is ranked 493.
Debt-to-Equity
Moderna, rank is 725
10 Day Gain
Moderna, rank is 893
Up EPS Surprise
Moderna, beat the consensus earnings estimate when it last reported quarterly earnings.
90 Day Gain
Moderna, rank is 3467
Negative Rankings
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (50.00%). Among companies that have had their estimates lowerec within the past month, Moderna, is ranked 38.
Price-to-Sales
Moderna, rank is 84
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Moderna, is ranked 100.
Price-to-Book
Moderna, rank is 249
Negative Net Margin
Moderna, rank is 293
Negative ROE
Moderna, rank is 752
Overbought Stochastics
Moderna, rank is 797
Negative ROA
Moderna, rank is 798
High Put/Call
Moderna, has a high Put/Call ratio of 0.82 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Moderna, is ranked 983.
High vPut/Call
Moderna, has a high Put/Call ratio of 0.44 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Moderna, is ranked 2238.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.